Qualigen Therapeutics, Inc. announced that it has appointed Shishir Sinha, the company's newly promoted Senior Vice President and current Chief Operating Officer, to lead the company's diagnostics division.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.309 USD | +7.29% | +10.28% | -43.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.82% | 1.95M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.96% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- QLGN Stock
- News Qualigen Therapeutics, Inc.
- Qualigen Therapeutics Appoints Shishir Sinha to Lead Diagnostics Division Following Promotion to Senior Vice President